Molecular mechanisms of inherited cardiomyopathies

Physiological Reviews

Volumn 82, Issue 4, 2002, Pages 945-980

  Fatkin, Diane ^a   Graham, Robert M ^a  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM BINDING PROTEIN; CALCIUM ION; CONNECTIN; DESMIN; DYSTROPHIN; GENOMIC DNA; LAMIN; MESSENGER RNA; MITOCHONDRIAL DNA; MYOSIN; MYOSIN HEAVY CHAIN; SARCOGLYCAN; TROPOMYOSIN; TROPONIN C; TROPONIN I; TROPONIN T; VINCULIN;

ARRHYTHMOGENESIS; CARDIOMYOPATHY; CHROMOSOMAL LOCALIZATION; CLINICAL FEATURE; GENE MUTATION; HEART ARRHYTHMIA; HEART DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOMERE;

EID: 0036787237     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00012.2002     Document Type: Review

References (182)

1. AHMAD F, LI D, KARÍBE A, GONZALEZ O, TAPSCOTT T, HILL R, WEILBAECHER D, BLACKIE P, FUREY M, GARDNER M, BACHINSKI LL, AND ROBERTS R. Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 98: 2791-2795, 1998.
2. ARAD M, BENSON DW, PEREZ-ATAYDE AR, MCKENNA WJ, SPARKS EA, KANTOR RJ, MCGARRY K, SEIDMAN JG, AND SEIDMAN CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109: 357-362, 2002.
3. ARBER S, HUNTER JJ, ROSS J, HONGO M, SANSIG G, BORG J, PERRIARD JC, CHIEN KR, AND CARONI P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88: 393-403, 1997,
4. ARBUSTINI E, DIEGOLI M, FASANI R, GRASSO M, MORBINI P, BANCHIERI N, BELLINI O, DAL BELLO B, PILOTTO A, MAGRINI G, CAMPANA C, FORTINA P, GAVAZZI A, NARULA J, AND VIGANO M. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153: 1501-1510, 1998.
5. ARBUSTINI E, DIEGOLI M, MORBINI P, DAL BELLO B, BANCHIERI N, PILOTTO A, MAGANI F, GRASSO M, NARULA J, GAVAZZI A, VIGANO M, AND TAVAZZI L. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35: 1760-1768, 2000.
6. ATKISON P, JOUBERT G, BARRON A, GRANT D, PARADIS K, SEIDMAN E, WALL W, ROSENBERG H, HOWARD J, WILLIAMS S, AND STILLER C. Hypertrophic cardiomyopathy associated with tacrolimus in paediattic transplant patients. Lancet 34: 894-896, 1995.
7. BECKER KD, GOTTSHALL KR, HICKEY R, PERRIARD JC, AND CHIEN KR. Point mutations in human β cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. J Cell Biol 137: 131-140, 1997.
8. BERS DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87: 275-281, 2000.
9. 2+ regulation of thin filament motility. Biochem Biophys Res Commun 236: 760-764, 1997.
10. BIONE S, D'ADAMO P, MAESTRINI E, GEDEON AK, BOLHUIS PA, AND TONIOLO D. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12: 385-389, 1996.
11. BLAIR E, REDWOOD C, ASHRAFIAN H, OLIVEIRA M, BROXHOLME J, KERR B, SALMON A, OSTMAN-SMITH I, AND WATKINS H. Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10: 1215-1220, 2001.
12. 403+ mouse model of familial hypertrophic cardiomyopathy. Circ Res 84: 475-483, 1999.
13. BLEYL SB, MUMFORD BR, THOMPSON V, CAREY JC, PYSHER TJ, CHIN TK, AND WARD K. Neonatal lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61: 868-872, 1997.
14. BONNE G, CARRIER L, BERCOVICI J, CRUAUD C, RICHARD P, HAINQUE B, GAUTEL M, LABEIT S, JAMES M, BECKMANN J, WEISSENBACH J, VOSBERG HP, FISZMAN M, KOMAJDA M, AND SCHWARTZ K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11: 438-440, 1995.
15. BONNE G, DI BARLETTA MR, VARNOUS S, BECANE HM, HAMMOUDA EH, MERLINI L, MUNTONI F, GREENBERG CR, GARY F, URTIZBEREA JA, DUBOC D, FARDEAU M, TONIOLO D, AND SCHWARTZ K. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21: 285-288, 1999.
16. BOTTINELLI R, COVIELLO DA, REDWOOD CS, PELLEGRINO MA, MARON BJ, SPIRITO P, WATKINS H, AND REGGIANI C. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 82: 106-115, 1998.
17. BOWLES KR, GAJARSKI R, PORTER P, GOYTIA V, BACHINSKI L, ROBERTS R, PIGNATELLI R, AND TOWBIN JA. Gene mapping of familial autosomal dominant dilatd cardiomyopathy to chromosome 10q21-q23. J Clin Invest 98: 1355-1360, 1996.
18. BRODSKY GL, MUNTONI F, MIOCIC S, SINAGRA G, SEWRY C, AND MESTRONI L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101: 473-476, 2000.
19. BROWN MS AND GOLDSTEIN JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
20. CAO H AND HEGELE RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9: 109-112, 2000.
21. CORAL-VAZQUEZ R, COHN RD, MOORE SA, HILL JA, WEISS RM, DAVISSON RL, STRAUB V, BARRESI R, BANSAI D, HRSTKA RF, WILLIAMSON R, AND CAMPBELL KP. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98: 465-474, 1999.
22. CORRADO D, BASSO C, THIENE G, MCKENNA WJ, DAVIES MJ, FONTALIRAN F, NAVA A, SILVESTRI F, BLOMSTROM-LUNDQVIST C, WLODARSKA EK, FONTAINE G, AND CAMERINI F. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30: 1512-1520, 1997.
23. CUDA G, FANANAPAZIR L, EPSTEIN ND, AND SELLERS JR. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hyper-trophic cardiomyopathy. J Muscle Res Cell Motil 18: 275-283, 1997.
24. D'ADAMO P, FASSONE L, GEDEON A, JANSSEN EAM, BIONE S, BOLHUIS PA, BARTH PG, WILSON M, HAAN E, ORSTAVIK KH, PATRON MA, GREEN AJ, ZAMMARCHI E, DONATI MA, AND TONIOLO D. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61: 862-867, 1997.
25. DALAKAS MC, PARK KY, SEMINO-MORA C, LEE HS, SIVAKUMAR K, AND GOLDFARB LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342: 770-780, 2000.
26. D'CRUZ LG, BABOONIAN C, PHILLIMORE HE, TAYLOR R, ELLIOTT PM, VARNAVA A, DAVISON F, MCKENNA WJ, AND CARTER ND. Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet 37: e18, 2000. (http:// jmedgenet.com/cgi/content/full/37/9/e18)
27. DEC GW AND FUSTER V. Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-1575, 1994.
28. DE WINDT LJ, LIM HW, BUENO OF, LIANG Q, DELLING U, BRAZ JC, GLASCOCK BJ, KIMBALL TF, DEL MONTE F, HAJJAR RJ, AND MOLKENTIN JD. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98: 3322-3327, 2001.
29. DURAND JB, BACHINSKI LL, BIELING LC, CZERNUSZEWICZ GZ, ABCHEE AB, YU QT, TAPSCOTT T, HILL R, IFEGWU J, MARIAN AJ, BRUGADA R, DAIGER S, GREGORITCH JM, ANDERSON JL, QUINONES M, TOWBIN JA, AND ROBERTS R. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 92: 3387-3389, 1995.
30. ELLIOTT K, WATKINS H, AND REDWOOD CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 275: 22069-22074, 2000.
31. ESPOSITO G, RAPACCIUOLO A, PRASAD SVN, TAKAOKA H, THOMAS SA, KOCH WJ, AND ROCKMAN HA. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105: 85-92, 2002.
32. FAMILIAL HYPERTROPHIC CARDIOMYOPATHY MUTATION DATABASE. http:// www.angis.org.au/Databases/Heart/.
33. FATKIN D, CHRISTE ME, ARISTIZABAL O, MCCONNELL BK, SRINIVASAN S, SCHOEN FJ, SEIDMAN CE, TURNBULL DH, AND SEIDMAN JG. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the a cardiac myosin heavy chain gene. J Clin Invest 103: 147-153, 1999.
34. FATKIN D, MACRAE C, SASAKI T, WOLFF MR, PORCU M, FRENNEAUX M, ATHERTON J, VIDAILLET HJ, SPUDICH S, DE GIROLAMI U, SEIDMAN JG, AND SEIDMAN CE. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341: 1715-1724, 1999.
35. 2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest 106: 1351-1359, 2000.
36. FRANZ WM, MULLER M, MUUER OJ, HERRMANN R, ROTHMANN T, CREMER M, COHN RD, VOIT T, AND KATUS HA. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 355: 1781-1785, 2000.
37. GAO WD, PEREZ NG, SEIDMAN CE, SEIDMAN JG, AND MARBAN E. Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy. J Clin Invest 103: 661- 666, 1999.
38. GAUTEL M, ZUFFARDI O, FREIBURG A, AND LABEIT S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14: 1952-1960, 1995.
39. GEIER C, OEZCELIK C, PERROT A, BIT-AVRAGIM N, SCHEFFOLD T, AND OSTERZIEL KJ. Muscle LIM protein: a novel disease gene for hypertrophic cardiomyopathy? Circulation 104 Suppl 11: 11-521, 2001.
40. GEISTERFER-LOWRANCE AAT, KASS S, TANIGAWA G, VOSBERG HP, MCKENNA W, SEIDMAN CE, AND SEIDMAN JG. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain missense mutation. Cell 62: 999-1006, 1990.
41. GEISTERFER-LOWRANCE AAT, CHRISTE M, CONNER DA, INGWALL JS, SCHOEN FJ, SEIDMAN CE, AND SEIDMAN JG. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996.
42. GENSCHEL J AND SCHMIDT HHJ. Mutations in the LMNA gene encoding lamin A/C. Hum Mutat 16: 451-459, 2000.
43. GEORGAKOPOULOS D, CHRISTE ME, GIEWAT M, SEIDMAN CE, SEIDMAN JG, AND KASS DA. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an α-cardiac myosin heavy chain missense mutation. Nat Med 5: 327-330, 1999.
44. GERULL B, GRAMLICH M, ATHERTON J, MCNABB M, TROMBITAS K, SASSEKLAASSEN S, SEIDMAN JG, SEIDMAN CE, GRANZIER H, LABEIT S, FRENNEAUX M, AND THIERFELDER L. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30: 201-204, 2002.
45. GILBERT R, KELLY MG, MIKAWA T, AND FISCHMAN DA. The carboxyl terminus of myosin binding protein C specifies incorporation into the A-band of striated muscle. J Cell Sci 109: 101-111, 1996.
46. GOLDFARB LG, PARK KY, CERVENAKOVA L, GOROKHOVA S, LEE HS, VASCONCELAS O, NAGLE JW, SEMINO-MORA C, SIVAKUMAR K, AND DALAKAS MC. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19: 402-403, 1998.
47. GOLLOB MH, GREEN MS, TANG ASL, GOLLOB T, KARIBE A, HASSAN AS, AHMAD F, LOZADO R, SHAH G, FANANAPAZIR L, BACHINSKI L, AND ROBERTS R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344: 1823-1831, 2001.
48. GRUEN M AND GAUTEL M. Mutations in the β-myosin S2 that cause familial hypertrophic cardiomyopathy abolish the interaction with the regulatory domain of myosin binding protein-C. J Mol Biol 286: 933-949, 1999.
49. GRUNIG E, TASMAN JA, KUCHERER H, FRANZ W, KUBLER W, AND KATUS HA. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31: 186-194, 1998.
50. HAGHIGHI K, SCHMIDT AG, HOIT BD, BRITTSAN AG, YATANI A, LESTER JW, ZHAI J, KIMURA Y, DORN GW, MACLENNAN DH, AND KRANIAS EG. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 276: 24145-24152, 2001.
51. HALLOPEAU M. Retrecissement ventriculoaortique. Gazette Medicale Paris 24: 683-684, 1869.
52. HART KA, HODGSON S, WALKER A, COLE CG, JOHNSON L, DUBOWITZ V, AND BOBROW M. DNA deletions in mild and severe Becker muscular dystrophy. Hum Genet 75: 281-285, 1987.
53. HELING A, ZIMMERMANN R, KOSTIN S, MAENO Y, HEIN S, DEVAUX B, BAUER E, KLOVEKORN WP, SCHLEPPER M, SCHAPER W, AND SCHAPER J. Increased expression of cytoskeletal, linkage and extracellular proteins in failing human myocardium. Circ Res 86: 846- 853, 2000.
54. HERTIG CM, BUTZ S, KOCH S, EPPENBERGER-EBERHARDT M, KEMLER R, AND EPPENBERGER HM. N-cadherin in adult rat cardiomyocytes in culture. II. Spatio-temporal appearance of proteins involved in cell-cell contact and communication. Formation of two distinct N-cadherin/catenin complexes. J Cell Sci 109: 11-20, 1996.
55. HO CY, LEVER HM, DESANCTIS R, FARVER CF, SEIDMAN JG, AND SEIDMAN CE. Homozygous mutation in cardiac troponin T. Implications for hypertrophic cardiomyopathy. Circulation 102: 1950-1955, 2000.
56. HOFFMANN B, SCHMIDT-TRAUB H, PERROT A, OSTERZIEL KJ, AND GEBNER R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 17: 524, 2001.
57. HOLMES KC AND GEEVES MA. The structural basis of muscle contraction. Philos Trans R Soc Lond 355: 419-431, 2000.
58. HUXLEY AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem 7: 255-318, 1957.
59. HUXLEY AF. Mechanics and models of the myosin motor. Philos Trans R Soc Lond 355: 433-440, 2000.
60. HUXLEY HE. The mechanism of muscular contraction. Science 164: 1356-1366, 1969.
61. JAMES J, ZHANG Y, OSINSKA H, SANBE A, KLEVITSKY R, HEWETT TE, AND ROBBINS J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 805-811, 2000.
62. JAMES TN, ST. MARTIN E, WILLIS PW, AND LOHR TO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node and internodal pathways. Circulation 93: 1424-1438, 1996.
63. JARCHO JA, MCKENNA W, PARE JAP, SOLOMON SD, HOLCOMBE RF, DICKIE S, LEVI T, DONIS-KELLER H, SEIDMAN JG, AND SEIDMAN CE. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql. N Engl J Med 321: 1372-1378, 1989.
64. JHA S, KAO A, DESAI S, ST. JOHN →SUTTON MG, JESSUP M, AND KEATING MT. Identification of a new locus for autosomal dominant dilated cardiomyopathy on chromosome 9q22-q31. Circulation 104 Suppl 11: 11-135, 2001.
65. JUNG M, POEPPING I, PERROT A, ELLMER AE, WIENKER TF, DIETZ R, REIS A, AND OSTERZIEL KJ. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am J Hum Genet 65: 1068-1077, 1999.
66. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97: 2536-2542, 1998.
67. KAMISAGO M, SHARMA SD, DEPALMA SR, SOLOMON S, SHARMA P, MC- DONOUGH B, SMOOT L, MULLEN MP, WOOLF PK, WIGLE ED, SEIDMAN JG, AND SEIDMAN CE. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343: 1688-1696, 2000.
68. KASS S, MACRAE C, GRABER HL, SPARKS EA, MCNAMARA D, BOUDOULAS H, BASSON CT, BAKER PB, CODY RJ, FISHMAN MC, COX N, KONG A, WOOLEY CF, SEIDMAN JG, AND SEIDMAN CE. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 7: 546-551, 1994.
69. KEELING PJ, GANG Y, SMITH G, SEO H, BENT SE, MURDAY V, CAFORIO ALP, AND MCKENNA WJ. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 73: 417-421, 1995.
70. KIM SJ, IIZUKA K, KELLY RA, GENG YJ, BISHOP SP, YANG G, KUDEJ A, MCCONNELL BK, SEIDMAN CE, SEIDMAN JG, AND VATNER SF. An α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol Heart Circ Physiol 276: H1780-H1787, 1999.
71. KIMURA A, HARADA H, PARK JE, NISHI H, SATOH M, TAKAHASHI M, HIROI S, SASAOKA T, OHBUCHI N, NAKAMURA T, KOYANAGI T, HWANG TH, CHOO JA, CHUNG KS, HASEGAWA A, NAGAI R, OKAZAKI O, NAKAMURA H, MATSUZAKI M, SAKAMOTO T, TOSHIMA H, KOGA Y, IMAIZUMI T, AND SASAZUKI T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382, 1997.
72. KOENIG M, HOFFMAN EP, BERTELSON CJ, MONACO AP, FEENER C, AND KUNKEL LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509-517, 1987.
73. KRAJINOVIC M, PINAMONTI B, SINAGRA G, VATTA M, SEVERINI GM, MILASIN J, FALASCHI A, CAMERINI F, GIACCA M, AND MESTRONI L. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet 57: 846-852, 1995.
74. KUNST G, KRESS KR, GRUEN M, UTTENWEILER D, GAUTEL M, AND FINK RHA. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res 86: 51-58, 2000.
75. KUSHWAHA SS, FALLON JT, AND FUSTER V. Restrictive cardiomyopathy. N Engl J Med 336: 267-276, 1997.
76. LAITINEN PJ, BROWN KM, PIIPPO K, SWAN H, DEVANEY JM, BRAHMBHATT B, DONARUM EA, MARINO M, TISO N, VIITASALO M, TOIVONEN L, STEPHAN DA, AND KONTULA K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103: 485-490, 2001.
77. LANKFORD EB, EPSTEIN ND, FANANAPAZIR L, AND SWEENEY HL. Abnormal contractile properties of muscle fibers expressing B-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 95: 1409-1414, 1995.
78. LEVINE RJC, YANG Z, EPSTEIN ND, FANANAPAZIR L, STULL JT, AND SWEENEY HL. Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. J Struct Biol 122; 149-161, 1998.
79. LI D, AHMAD F, GARDNER MJ, WEILBAECHER D, HILL R, KARIBE A, GONZALEZ O, TAPSCOTT T, SHARRATT GP, BACHINSKI LL, AND ROBERTS R. The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterised by early onset and high penetrance maps to chromosome 10p12-p14. Am J Hum Genet 66: 148-156, 2000.
80. LI D, TAPSCOFT T, GONZALEZ O, BURCH PE, QUINONES MA, ZOGHBI WA, HILL R, BACHINSKI LL, MANN DL, AND ROBERTS R. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100: 461-464, 1999.
81. LI YY, MAISCH B, ROSE ML, AND HENGSTENBERG C. Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. J Mol Cell Cardiol 29: 2699-2709, 1997.
82. LIM DS, OBERST L, MCCLUGGAGE M, YOUKER K, LACY J, DEMAYO F, ENTMAN ML, ROBERTS R, MICHAEL LH, AND MARIAN AJ. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 365-374, 2000.
83. LIN D, BOBKOVA A, HOMSHER E, AND TOBACMAN LS. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 97: 2842-2848, 1996.
84. LYMN RW AND TAYLOR EW. Mechanism of adenosine triphosphate hydrolysis by actomyosin. Biochemistry 10: 4617-4624, 1971.
85. MAEDA M, HOLDER E, LOWES B, VALENT S, AND BIES RD. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95: 17-20, 1997.
86. MALLAT Z, TEDGUI A, FONTALIRAN F, FRANK R, DURIGON M, AND FONTAINE G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335: 1190-1196, 1996.
87. MARIAN AJ, YU QT, MANN DL, GRAHAM FL, AND ROBERTS R. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res 77: 98-106, 1995.
88. MARIAN AJ, ZHAO G, SETA Y, ROBERTS R, AND YU Q. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res 81: 76-85, 1997.
89. MARIN-GARCIA J AND GOLDENTHAL MJ. Mitochondrial cardiomyopathy: molecular and biochemical analysis. Pediatr Cardiol 18: 251-260, 1997.
90. MARIN-GARCIA J, GOLDENTHAL MJ, ANANTHAKRISHNAN R, PIERPONT MEM, FRICKER FJ, LIPSHULTZ SE, AND PEREZ-ATAYDE A. Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 31: 306-313, 1996.
91. MARON BJ, GARDIN JM, FLACK JM, GIDDING SS, KUROSAKI TT, AND BILD DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92: 785-789, 1995.
92. MARX SO, REIKEN S, HISAMATSU Y, JAYARAMAN T, BURKHOFF D, ROSEMBLIT N, AND MARKS AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
93. MAYOSI BM, KHOGALI S, ZHANG B, AND WATKINS H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 36: 796-797, 1999.
94. MCCARTHY TV, QUANE KA, AND LYNCH PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 15: 410-417, 2000.
95. MCCONNELL BK, FATKIN D, SEMSARIAN C, JONES KA, GEORGAKOPOULOS D, MAGUIRE CT, HEALEY MJ, MUDD JO, MOSKOWITZ IPG, CONNER DA, GIEWAT M, WAKIMOTO H, BERUL CI, SCHOEN FJ, KASS DA, SEIDMAN CE, AND SEIDMAN JG. Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res 88: 383-389, 2001.
96. MCCONNELL BK, JONES KA, FATKIN D, ARROYO LH, LEE RT, ARISTIZABAL O, TURNBULL DH, GEORGAKOPOULOS D, KASS D, BOND M, NIIMURA H, SCHOEN FJ, CONNER D, FISCHMAN DH, SEIDMAN CE, AND SEIDMAN JG. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104: 1235-1244, 1999.
97. MCDONALD KS AND MOSS RL. Strongly binding myosin crossbridges regulate loaded shortening and power output in cardiac myocytes. Circ Res 87: 768-773, 2000.
98. MCKOY G, PROTONOTARIOS N, CROSBY A, TSATSOPOULOU A, ANASTASAKIS A, COONAR A, NORMAN M, BABOONIAN C, JEFFERY S, AND MCKENNA WJ. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355: 2119-2124, 2000.
99. MELBERG A, OLDFORS A, BLOMSTROM-LUNDQVIST C, STALBERG E, CARLSSON B, LARSSON E, LIDELL C, EEG-OLOFSSON KE, WIKSTROM G, HENRIKSSON KG, AND DAHL N. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 46: 684-692, 1999.
100. MESSINA DN, SPEER MC, PERICAK-VANCE MA, AND MCNALLY EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 61: 909-917, 1997.
101. MESTRONI L, ROCCO C, GREGORI D, SINAGRA G, DI LENARDA A, MIOCIC S, VATTA M, PINAMONTI B, MUNTONI F, CAFORIO ALP, MCKENNA WJ, FALASCHI A, GIACCA M, AND CAMERINI F. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 34: 181-190, 1999.
102. MICHELS VV, MOLL PP, MILLER FA, TAJIK AJ, CHU JS, DRISCOLL DJ, BURNETT JC, RODEHEFFER RJ, CHESEBRO JH, AND TAZELAAR HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326: 77-82, 1992.
103. MILLER T, SZCZESNA D, HOUSMANS PR, ZHAO J, DE FREITAS F, GOMES AV, CULBREATH L, MCCUE J, WANG Y, XU Y, KERRICK WG, AND POTTER JD. Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (1180) mutation. J Biol Chem 276: 3743-3755, 2001.
104. MILNER DJ, WEITZER G, TRAN D, BRADLEY A, AND CAPETANAKI Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134: 1255-1270, 1996.
105. MOLKENTIN JD, LU JR, ANTOS C, MARKHAM B, RICHARDSON J, ROBBINS J, GRANT SR, AND OLSON EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
106. MOOLMAN JC, CORFIELD VA, POSEN B, NGUMBELA K, SEIDMAN CE, BRINK PA, AND WATKINS H. Sudden death due to troponin T mutations. J Am Coll Cardiol 29: 549-555, 1997.
107. 2+-desensitizing effect of a deletion mutation δK210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99: 913-918, 2002.
108. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol Cell Physiol 275: C200-C207, 1998.
109. MUCHIR A, BONNE G, VAN DER KOOI AJ, VAN MEEGEN M, BAAS F, BOLHUIS PA, DE VISSER M, AND SCHWARTZ K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9: 1453-1459, 2000.
110. MUNTONI F, MELIS MA, GANAU A, AND DUBOWITZ V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet 56: 151-157, 1995.
111. MUNTONI F, WILSON L, MARROSU G, MARROSU MG, CIANCHETTI C, MESTRONI L, GANAU A, DUBOWITZ V, AND SEWRY C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 96: 693-699, 1995.
112. MUTHUCHAMY M, PIEPLES K, RETHINASAMY P, HOIT B, GRUPP IL, BOIVIN GP, WOLSKA B, EVANS C, SOLARO RJ, AND WIECZOREK DF. Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction. Circ Res 85: 47-56, 1999.
113. NARULA J, HAIDER N, VIRMANI R, DISALVO TG, KOLODGIE FD, HAJJAR RJ, SCHMIDT U, SEMIGRAN MJ, DEC GW, AND KHAW BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335: 1182-1189, 1996.
114. NIGRO V, DE SA MOREIRA E, PILUSO G, VAINZOF M, BELSITO A, POLITANO L, PUCA AA, PASSOS-BUENO MR, AND ZATZ M. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 14: 195-198, 1996.
115. NIGRO V, OKAZAKI Y, BELSITO A, PILUSO G, MATSUDA Y, POLITANO L, NIGRO G, VENTURA C, ABBONDANZA C, MOLINARI AM, ACAMPORA D, NISHIMURA M, HAYASHIZAKI Y, AND PUCA GA. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6: 601-607, 1997.
116. NUMURA H, BACHINSKI LL, SANGWATANAROJ S, WATKINS H, HUDLEY AE, MCKENNA W, KRISTINSSON A, ROBERTS R, SOLE M, MARON BJ, SEIDMAN JG, AND SEIDMAN CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248-1257, 1998.
117. OBERST L, ZHAO G, PARK JT, BRUGADA R, MICHAEL LH, ENTMAN ML, ROBERTS R, AND MARIAN AJ. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 102: 1498-1505, 1998.
118. OLSON EN AND MOLKENTIN JD. Prevention of cardiac hypertrophy by calcineurin inhibition. Hope or hype? Circ Res 84: 623-632, 1999.
119. OLSON TM, DOAN TP, KISHIMOTO NY, WHITBY FG, ACKERMAN MJ, AND FANANAPAZIR L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1687-1694, 2000.
120. OLSON TM, ILLENBERGER S, KISHIMOTO NY, HUTTELMAIER S, KEATING MT, AND JOCKUSCH BM. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105: 431-437, 2002.
121. OLSON TM AND KEATING MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 97: 528-532, 1996.
122. OLSON TM, KISHIMOTO NY, WHITBY FG, AND MICHELS VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33: 723-732, 2001.
123. OLSON TM, MICHELS VV, THIBODEAU SN, TAI YS, AND KEATING MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752, 1998.
124. PALKA HL AND GREEN KJ. Roles of plakoglobin end domains in desmosome assembly. J Cell Sci 110: 2359-2371, 1997.
125. POETRER K, JIANG H, HASSANZADEH S, MASTER SR, CHANG A, DALAKAS MC, RAYMENT I, SELLERS JR, FANANAPAZIR L, AND EPSTEIN ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63-69, 1996.
126. PRIORI SG, NAPOLITANO C, TISO N, MEMMI M, VIGNATI G, BLOISE R, SORRENTINO V, AND DANIELI GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196-200, 2001.
127. RAMPAZZO A, NAVA A, DANIELI GA, BUJA G, DALIENTO L, FASOLI G, SCOGNAMIGLIO R, CORRADO D, AND THIENE G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 3: 959-962, 1994.
128. RAMPAZZO A, NAVA A, ERNE P, EBERHARD M, VIAN E, SLOMP P, TISO N, THIENE G, AND DANIELI GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 4: 2151-2154, 1995.
129. RAMPAZZO A, NAVA A, MIORIN M, FONDERICO P, POPE B, TISO N, LIVOLSI B, ZIMBELLO R, THIENE G, AND DANIELI GA. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 45: 259-263, 1997.
130. RAYMENT I, HOLDEN HM, SELLERS JR, FANANAPAZIR L, AND EPSTEIN ND. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 92: 3864-3868, 1995.
131. RAYMENT I, HOLDEN HM, WHITTAKER M, YOHN CB, LORENZ M, HOLMES KC, AND MILLIGAN RA. Structure of the actin-myosin complex and its implications for muscle contraction. Science 261: 58-65, 1993.
132. REDWOOD C, LOHMANN K, BING W, ESPOSITO GM, ELLIOTT K, ABDUL-RAZZAK H, KNOTT A, PURCELL I, MARSTON S, AND WATKINS H, Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy. Circ Res 86: 1146-1152, 2000.
133. 2+ regulation of thin filaments (Abstract). Biophys J 74: A354, 1998.
134. REGITZ-ZAGROSEK V, DAEHMLOW S, KNUEPPEL T, KOTSCH K, GILLE C, FROEMMEL C, ELSNER A, HUMMEL M, AND HETZER R. Novel mutations in the β myosin heavy chain and myosin binding protein C gene are associated with dilated cardiomyopathy. Circulation 104 Suppl 11: 11-572, 2001.
135. REPORT OF THE 1995 WORLD HEALTH ORGANIZATION/INTERNATIONAL SOCIETY AND FEDERATION OF CARDIOLOGY TASK FORCE. The definition and classification of cardiomyopathies. Circulation 93: 841-842, 1996.
136. RICHARD P, CHARRON P, LECLERCQ C, LEDEUIL C, CARRIER L, DUBOURG O, DESNOS M, BOUHOUR JB, SCHWARTZ K, DAUBERT JC, KOMAJDA M, AND HAINQUE B. Homozygotes for a R869G mutation in the beta-myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1575-1583, 2000.
137. ROTHERMEL BA, MCKINSEY TA, VEGA RB, NICOL RL, MAMMEN P, YANG J, ANTOS CL, SHELTON JM, BASSEL-DUBY R, OLSON EN, AND WILLIAMS RS. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98: 3328-3333, 2001.
138. ROTTBAUER W, GAUTEL M, ZEHELEIN J, LABEIT S, FRANZ WM, FISCHER C, VOLLRATH B, MALL G, DIETZ R, KUBLER W, AND KATUS HA. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. J Clin Invest 100: 475-482, 1997.
139. RUST EM, ALBAYYA FP, AND METZGER JM. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest 103: 1459-1467, 1999.
140. SANBE A, GULICK J, HAYES E, WARSHAW D, OSINSKA H, CHAN CB, KLEVITSKY R, AND ROBBINS J. Myosin light chain replacement in the heart. Am J Physiol Heart Circ Physiol 279: H1355-H1364, 2000.
141. SANBE A, NELSON D, GULICK J, SETSER E, OSINSKA H, WANG X, HEWETT TE, KLEVITSKY R, HAYES E, WARSHAW DM, AND ROBBINS J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 296-302, 2000.
142. SATA M AND IKEBE M. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J Clin Invest 98: 2866-2873, 1996.
143. SATOH M, TAKAHASHI M, SAKAMOTO T, HIROE M, MARUMO F, AND KIMURA A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262: 411-417, 1999.
144. SCHONBERGER J, LEVY H, GRUNIG E, SANGWATANAROJ S, FATKIN D, MACRAE C, STACKER H, HALPIN C, EAVEY R, PHILBIN EF, KATUS H, SEIDMAN JG, AND SEIDMAN CE. Dilated cardiomyopathy and sensorineural hearing loss. A heritable syndrome that maps to chromosome 6q23-q24. Circulation 101: 1812-1818, 2000.
145. SEVERINI GM, KRAJINOVIC M, PINAMONTI B, SINAGRA G, FIORETTI P, BRUNAZZI MC, FALASCHI A, CAMERINI F, GIACCA M, AND MESTRONI L. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 31: 193-200, 1996.
146. SHACKLETON S, LLOYD DJ, JACKSON SNJ, EVANS R, NIERMEIJER MF, SINGH BM, SCHMIDT H, BRABANT G, KUMAR S, DURRINGTON PN, GREG- ORY S, O'RAHILLY S, AND TREMBATH RC. LMNA, encoding lamin A/C is mutated in partial lipodystrophy. Nat Genet 24: 153-156, 2000.
147. SIU BL, NIIMURA H, OSBORNE JA, FATKIN D, MACRAE C, SOLOMON S, BENSON DW, SEIDMAN JG, AND SEIDMAN CE. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation 99: 1022-1026, 1999.
148. SOLARO RJ AND VAN EYK J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 28: 217-230, 1996.
149. 403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 101: 1775-1783, 1998.
150. STUURMAN N, HEINS S, AND AEBI U. Nuclear lamins: their structure, assembly and interactions. J Struct Biol 122: 42-66, 1998.
151. SUGDEN PH. Signaling in myocardial hypertrophy. Life after calcineurin? Circ Res 84: 633-646, 1999.
152. SULLIVAN T, ESCALANTE-ALCALDE D, BRATT H, ANVER M, BHAT N, NAGASHIMA K, STEWART CL, AND BURKE B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147: 913-919, 1999.
153. SUOMALAINEN A, PAETAU A, LEINONEN H, MAJANDER A, PELTONEN L, AND SOMER H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340: 1319-1320, 1992.
154. SWEENEY HL, FENG HS, YANG Z, AND WATKINS H. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci USA 95: 14406-14410, 1998.
155. SWEENEY HL, STRACESKI AJ, LEINWAND LA, TIKUNOV BA, AND FAUST L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 269: 1603-1605, 1994.
156. SYLVIUS N, TESSON F, GAYET C, CHARRON P, BENAICHE A, MANGIN L, PEUCHMAURD M, DUBOSCQ-BIDOT L, FEINGOLD J, BECKMANN JS, BOUCHIER C, AND KOMAJDA K. A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16. Am J Hum Genet 68: 241-246, 2001.
157. SZCZESNA D, ZHANG R, ZHAO J, JONES M, GUZMAN G, AND POTTER JD. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem 275: 624-630, 2000.
158. TAKAHASHI-YANAGA F, MORIMOTO S, AND OHTZUKI I. Effect of Arg145Gly mutation in human cardiac troponin I on the ATPase activity of cardiac myofibrils. J Biochem 127: 355-357, 2000.
159. TAKAI E, AKITA H, SHIGA N, KANAZAWA K, YAMADA S, TERASHIMA M, MATSUDA Y, IWAI C, KAWAI K, YOKOTA Y, AND YOKOYAMA M. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet 86: 325-327, 1999.
160. TAKEMURA G, OHNO M, HAYAKAWA Y, MISAO J, KANOH M, OHNO A, UNO Y, MINATOGUCHI S, FUJIWARA T, AND FUJIWARA H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82: 1130-1138, 1998.
161. TARDIFF JC, FACTOR SM, TOMPKINS BD, HEWETT TE, PALMER BM, MOORE RL, SCHWARTZ S, ROBBINS J, AND LEINWAND LA. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest 101: 2800-2811, 1998.
162. TARDIFF JC, HEWETT TE, PALMER BM, OLSSON C, FACTOR SM, MOORE RL, ROBBINS J, AND LEINWAND LA. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104: 469-481, 1999.
163. TESSON F, SYLVIUS N, PILOTTO A, DUBOSQ-BIDOT L, PEUCHMAURD M, BOUCHIER C, BENAICHE A, MANGIN L, CHARRON P, GAVAZZI A, TAVAZZI L, ARBUSTINI E, AND KOMAJDA M. Epidmiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy. Eur Heart J 21: 1872-1876, 2000.
164. THIENE G, BASSO C, DANIELI G, RAMPAZZO A, CORRADO D, AND NAVA A. Arrhythmogenic right ventricular cardiomyopathy. Trends Cardiovasc Med 7: 84-90, 1997.
165. THIERFELDER L, WATKINS H, MACRAE C, LAMAS R, MCKENNA W, VOSBERG HP, SEIDMAN JG, AND SEIDMAN CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 710-712, 1994.
166. TISO N, STEPHAN DA, NAVA A, BAGATTIN A, DEVANEY JM, STANCHI F, LARDERET G, BRAHMBHATT B, BROWN K, BAUCE B, MURIAGO M, BASSO C, THIENE G, DANIELLI GA, AND RAMPAZZO A. Identification of muta- tions in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10: 189-194, 2001.
167. TOWBIN JA, HEJTMANCIK JF, BRINK P, GELB B, ZHU XM, CHAMBERLAIN JS, MCCABE ERB, AND SWIFT M. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87: 1854-1865, 1993.
168. TSUBATA S, BOWLES KR, VATTA M, ZINTZ C, TITUS J, MUHONEN L, BOWLES NE, AND TOWBIN JA. Mutations in the human 8-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106: 655-662, 2000.
169. TYSKA MJ, HAYES E, GIEWAT M, SEIDMAN CE, SEIDMAN JG, AND WARSHAW DM. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86: 737-744, 2000.
170. VIKSTROM KL AND LEINWAND LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol 8: 97-105, 1996.
171. WANNENBURG T, HEIJNE GH, GEERDINK JH, VAN DEN DOOL HW, JANSSEN PML, AND DE TOMBE PP. Cross-bridge kinetics in rat myocardium: effect of sarcomere length and calcium activation. Am J Physiol Heart Circ Physiol 279: H779-H790, 2000.
172. WATKINS H, CONNER D, THIERFELDER L, JARCHO JA, MACRAE C, MC-KENNA W, MARON BJ, SEIDMAN JG, AND SEIDMAN CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11: 434-437, 1995.
173. WATKINS H, MCKENNA WJ, THIERFELDER L, SUK HJ, ANAN R, O'DONOGHUE A, SPIRITO P, MATSUMORI A, MORAVEC CS, SEIDMAN JG, AND SEIDMAN CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064, 1995.
174. WATKINS H, ROSENZWEIG A, HWANG DS, LEVI T, MCKENNA W, SEIDMAN CE, AND SEIDMAN JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114, 1992.
175. WATKINS H, SEIDMAN CE, SEIDMAN JG, FENG HS, AND SWEENEY HL. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest 98: 2456-2461, 1996.
176. WEISBERG A AND WINEGRAD S. Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ Res 83: 60-72, 1998.
177. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274: 8806-8812, 1999.
178. YANAGIDA T, ESAKI S, IWAINE AH, INOUE Y, ISHIJIMA A, KITAMURA K, TANAKA H, AND TOKUNAGA M. Single-motor mechanics and models of the myosin motor. Philos Trans R Soc Lond 355: 441-447, 2000.
179. YANG J, MORAVEC CS, SUSSMAN MA, DIPAOLA NR, FU D, HAWTHORN L, MITCHELL CA, YOUNG JB, FRANCIS GS, MCCARTHY PM, AND BOND M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102: 3046-3052, 2000.
180. YANG Q, SANBE A, OSINSKA H, HEWETT TE, KLEVITSKY R, AND ROBBINS J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 102: 1292-1300, 1998.
181. ZOLK O, CARONI P, AND BOHM M. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation 101: 2674-2677, 2000.
182. ZOU Y, HIROI Y, UOZUMI H, TAKIMOTO E, TOKO H, ZHU W, KUDOH S, MIZUKAMI M, SHIMOYAMA M, SHIBASAKI F, NAGAI R, YAZAKI Y, AND KOMURO I. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 104: 97-101, 2001.